Clinical Trials Browser

Phase EARLY_PHASE1 × semaglutide × 90 days × Clear all

NCT07627191 2026-06-05

GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Colorectal Neoplasms